What's in Elliot Israel, MD's pipeline?

Elliot Israel, MD has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Elliot Israel, MD's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Azienda Policlinico Umberto I, Deutsches Herzzentrum Muenchen, Research Maatschap Cardiologen Rotterdam Zuid, Sanofi.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/elliot-israel-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Elliot Israel, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Elliot Israel, MD pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Prasugrel Oral Tablet	Prasugrel Oral Tablet	marketed	P2Y12 receptor antagonist (thienopyridine)	P2Y12 receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Azienda Policlinico Umberto I · 1 shared drug class
Deutsches Herzzentrum Muenchen · 1 shared drug class
Research Maatschap Cardiologen Rotterdam Zuid · 1 shared drug class
Sanofi · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Elliot Israel, MD:

Cite this brief

Drug Landscape (2026). Elliot Israel, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/elliot-israel-md. Accessed 2026-05-17.